BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6822433)

  • 1. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.
    Lecara G; Cox RA; Simpson RB
    Infect Immun; 1983 Jan; 39(1):473-5. PubMed ID: 6822433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
    Jiang C; Magee DM; Quitugua TN; Cox RA
    Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of mycelia- and spherule-derived antigens in cellular immune assays of Coccidioides immitis-infected guinea pigs.
    Cox RA; Mead CG; Pavey EF
    Infect Immun; 1981 Feb; 31(2):687-92. PubMed ID: 7012017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of alkali-soluble, water-soluble cell wall antigen of Coccidioides immitis with anti-Coccidioides immunoglobulin M precipitin antibody.
    Cox RA; Huppert M; Starr P; Britt LA
    Infect Immun; 1984 Feb; 43(2):502-7. PubMed ID: 6420343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic heterogeneity of an alkali-soluble, water-soluble cell wall extract of Coccidioides immitis.
    Cox RA; Britt LA
    Infect Immun; 1985 Nov; 50(2):365-9. PubMed ID: 4055022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
    Jiang C; Magee DM; Ivey FD; Cox RA
    Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
    Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
    Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
    Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
    Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression by cell wall antigens of Coccidioides immitis.
    Cox RA
    Rev Infect Dis; 1988; 10 Suppl 2():S415-8. PubMed ID: 3263691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of antigenic (species-specific?) partially 3-O-methylated heteromannans in cell wall and soluble cellular (nonwall) components of Coccidioides immitis mycelia.
    Wheat RW; Woodruff WW; Haltiwanger RS
    Infect Immun; 1983 Aug; 41(2):728-34. PubMed ID: 6874073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
    Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
    Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination.
    Galgiani JN; Sun SH; Dugger KO; Ampel NM; Grace GG; Harrison J; Wieden MA
    Infect Immun; 1992 Jul; 60(7):2627-35. PubMed ID: 1612732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-type hypersensitivity responses to a cell wall fraction of the mycelial phase of Coccidioides immitis.
    Ward ER; Cox RA; Schmitt JA; Huppert M; Sun SH
    Infect Immun; 1975 Nov; 12(5):1093-7. PubMed ID: 1193725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of mice against coccidioidomycosis with a subcellular vaccine.
    Pappagianis D; Hector R; Levine HB; Collins MS
    Infect Immun; 1979 Jul; 25(1):440-5. PubMed ID: 478645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
    Hurtgen BJ; Hung CY
    Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of T-lymphocyte response by Coccidioides immitis antigen.
    Cox RA; Kennell W
    Infect Immun; 1988 Jun; 56(6):1424-9. PubMed ID: 3259545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coccidioides immitis antigen.
    Pappagianis D
    J Infect Dis; 1999 Jul; 180(1):243-4. PubMed ID: 10353891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.